February 23, 2022 Comments Off on New patent for Otsuka drug ABILIFY MYCITE KIT Posted in: Patent Added Annual Drug Patent Expirations for ABILIFY+MYCITE+KIT Abilify Mycite Kit is a drug marketed by Otsuka and is included in one NDA. It is available from one supplier. There are thirty-one…
The post New patent for Otsuka drug ABILIFY MYCITE KIT appeared f…
February 23, 2022 Comments Off on New tentative approval for Zydus Pharms drug roflumilast Posted in: Tentative Approval Roflumilast is the generic ingredient in two branded drugs marketed by Astrazeneca, Breckenridge, Hetero Labs Ltd Iii, Micro Labs, Mylan, Strides Pharma, and Torrent and, and is included in seven…
The post New tentative approval for Zydus Pharms drug r…